Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
1,910,829
-
Total 13F shares
-
887,525
-
Share change
-
+887,525
-
Total reported value
-
$5,096,477
-
Price per share
-
$5.77
-
Number of holders
-
24
-
Value change
-
+$5,096,477
-
Number of buys
-
24
Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q2 2025
As of 30 Jun 2025,
Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
887,525 shares.
The largest 10 holders included
Vivo Capital, LLC, TANG CAPITAL MANAGEMENT LLC, Sofinnova Investments, Inc., Pivotal bioVenture Partners Investment Advisor LLC, VANGUARD GROUP INC, Nan Fung Group Holdings Ltd, SAMSARA BIOCAPITAL, LLC, Board of Trustees of The Leland Stanford Junior University, Pfizer Inc, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.